Literature DB >> 25103195

Influence of oligomerization state on the structural properties of invasion plasmid antigen B from Shigella flexneri in the presence and absence of phospholipid membranes.

Philip R Adam1, Nicholas E Dickenson, Jamie C Greenwood, Wendy L Picking, William D Picking.   

Abstract

Shigella flexneri causes bacillary dysentery, an important cause of mortality among children in the developing world. Shigella secretes effector proteins via its type III secretion system (T3SS) to promote bacterial uptake into human colonic epithelial cells. The T3SS basal body spans the bacterial cell envelope anchoring a surface-exposed needle. A pentamer of invasion plasmid antigen D lies at the nascent needle tip and invasion plasmid antigen B (IpaB) is recruited into the needle tip complex on exposure to bile salts. From here, IpaB forms a translocon pore in the host cell membrane. Although the mechanism by which IpaB inserts into the membrane is unknown, it was recently shown that recombinant IpaB can exist as either a monomer or tetramer. Both of these forms of IpaB associate with membranes, however, only the tetramer forms pores in liposomes. To reveal differences between these membrane-binding events, Cys mutations were introduced throughout IpaB, allowing site-specific fluorescence labeling. Fluorescence quenching was used to determine the influence of oligomerization and/or membrane association on the accessibility of different IpaB regions to small solutes. The data show that the hydrophobic region of tetrameric IpaB is more accessible to solvent relative to the monomer. The hydrophobic region appears to promote membrane interaction for both forms of IpaB, however, more of the hydrophobic region is protected from solvent for the tetramer after membrane association. Limited proteolysis demonstrated that changes in IpaB's oligomeric state may determine the manner by which it associates with phospholipid membranes and the subsequent outcome of this association.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Shigella; Stern-Volmer; fluorescence quenching; membrane; protein-lipid

Mesh:

Substances:

Year:  2014        PMID: 25103195      PMCID: PMC4206658          DOI: 10.1002/prot.24662

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  31 in total

1.  Structure and composition of the Shigella flexneri "needle complex", a part of its type III secreton.

Authors:  A Blocker; N Jouihri; E Larquet; P Gounon; F Ebel; C Parsot; P Sansonetti; A Allaoui
Journal:  Mol Microbiol       Date:  2001-02       Impact factor: 3.501

2.  Conformational changes in IpaD from Shigella flexneri upon binding bile salts provide insight into the second step of type III secretion.

Authors:  Nicholas E Dickenson; Lingling Zhang; Chelsea R Epler; Philip R Adam; Wendy L Picking; William D Picking
Journal:  Biochemistry       Date:  2010-12-15       Impact factor: 3.162

3.  Ultrastructural analysis of IpaD at the tip of the nascent MxiH type III secretion apparatus of Shigella flexneri.

Authors:  Chelsea R Epler; Nicholas E Dickenson; Esther Bullitt; Wendy L Picking
Journal:  J Mol Biol       Date:  2012-04-02       Impact factor: 5.469

4.  Identification of functional regions within invasion plasmid antigen C (IpaC) of Shigella flexneri.

Authors:  W L Picking; L Coye; J C Osiecki; A Barnoski Serfis; E Schaper; W D Picking
Journal:  Mol Microbiol       Date:  2001-01       Impact factor: 3.501

5.  Binding affects the tertiary and quaternary structures of the Shigella translocator protein IpaB and its chaperone IpgC.

Authors:  Philip R Adam; Mrinalini K Patil; Nicholas E Dickenson; Shyamal Choudhari; Michael Barta; Brian V Geisbrecht; Wendy L Picking; William D Picking
Journal:  Biochemistry       Date:  2012-05-01       Impact factor: 3.162

6.  The structures of coiled-coil domains from type III secretion system translocators reveal homology to pore-forming toxins.

Authors:  Michael L Barta; Nicholas E Dickenson; Mrinalini Patil; Andrew Keightley; Gerald J Wyckoff; William D Picking; Wendy L Picking; Brian V Geisbrecht
Journal:  J Mol Biol       Date:  2012-02-01       Impact factor: 5.469

7.  Oligomeric states of the Shigella translocator protein IpaB provide structural insights into formation of the type III secretion translocon.

Authors:  Nicholas E Dickenson; Shyamal P Choudhari; Philip R Adam; Ryan M Kramer; Sangeeta B Joshi; C Russell Middaugh; Wendy L Picking; William D Picking
Journal:  Protein Sci       Date:  2013-03-18       Impact factor: 6.725

8.  Broadly protective Shigella vaccine based on type III secretion apparatus proteins.

Authors:  Francisco J Martinez-Becerra; Julian M Kissmann; Jovita Diaz-McNair; Shyamal P Choudhari; Amy M Quick; Gabriela Mellado-Sanchez; John D Clements; Marcela F Pasetti; Wendy L Picking
Journal:  Infect Immun       Date:  2011-12-27       Impact factor: 3.441

9.  The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host membranes.

Authors:  A Blocker; P Gounon; E Larquet; K Niebuhr; V Cabiaux; C Parsot; P Sansonetti
Journal:  J Cell Biol       Date:  1999-11-01       Impact factor: 10.539

10.  Spontaneous formation of IpaB ion channels in host cell membranes reveals how Shigella induces pyroptosis in macrophages.

Authors:  L Senerovic; S P Tsunoda; C Goosmann; V Brinkmann; A Zychlinsky; F Meissner; M Kolbe
Journal:  Cell Death Dis       Date:  2012-09-06       Impact factor: 8.469

View more
  9 in total

1.  Type 3 Secretion Translocators Spontaneously Assemble a Hexadecameric Transmembrane Complex.

Authors:  Fabian B Romano; Yuzhou Tang; Kyle C Rossi; Kathryn R Monopoli; Jennifer L Ross; Alejandro P Heuck
Journal:  J Biol Chem       Date:  2016-01-19       Impact factor: 5.157

2.  Interfacial amino acids support Spa47 oligomerization and shigella type three secretion system activation.

Authors:  Hannah J Demler; Heather B Case; Yalemi Morales; Abram R Bernard; Sean J Johnson; Nicholas E Dickenson
Journal:  Proteins       Date:  2019-06-21

3.  Novel Noncompetitive Type Three Secretion System ATPase Inhibitors Shut Down Shigella Effector Secretion.

Authors:  Heather B Case; Dominic S Mattock; Bill R Miller; Nicholas E Dickenson
Journal:  Biochemistry       Date:  2020-06-30       Impact factor: 3.162

4.  Using disruptive insertional mutagenesis to identify the in situ structure-function landscape of the Shigella translocator protein IpaB.

Authors:  Michael L Barta; Shoichi Tachiyama; Meenakumari Muthuramalingam; Olivia Arizmendi; Cecilia E Villanueva; Kasra X Ramyar; Brian V Geisbrecht; Scott Lovell; Kevin P Battaile; Wendy L Picking; William D Picking
Journal:  Protein Sci       Date:  2018-05-03       Impact factor: 6.725

5.  Chlamydia Outer Protein (Cop) B from Chlamydia pneumoniae possesses characteristic features of a type III secretion (T3S) translocator protein.

Authors:  David C Bulir; Daniel A Waltho; Christopher B Stone; Steven Liang; Christopher K W Chiang; Kenneth A Mwawasi; Jordan C Nelson; Steven W Zhang; Samantha P Mihalco; Zachariah C Scinocca; James B Mahony
Journal:  BMC Microbiol       Date:  2015-08-14       Impact factor: 3.605

Review 6.  The Many Faces of IpaB.

Authors:  Wendy L Picking; William D Picking
Journal:  Front Cell Infect Microbiol       Date:  2016-02-09       Impact factor: 5.293

Review 7.  Bacterial Control of Pores Induced by the Type III Secretion System: Mind the Gap.

Authors:  Julie Guignot; Guy Tran Van Nhieu
Journal:  Front Immunol       Date:  2016-03-09       Impact factor: 7.561

8.  Phosphomimetic Tyrosine Mutations in Spa47 Inhibit Type Three Secretion ATPase Activity and Shigella Virulence Phenotype.

Authors:  Koleton D Hardy; Nicholas E Dickenson
Journal:  Pathogens       Date:  2022-02-03

9.  Dominant negative effects by inactive Spa47 mutants inhibit T3SS function and Shigella virulence.

Authors:  Jamie L Burgess; Heather B Case; R Alan Burgess; Nicholas E Dickenson
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.